コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 kinase 2 (CDK2), CDK4 and proliferating cell nuclear antigen.
2 nd the replication clamp, proliferating cell nuclear antigen.
3 ions and by immunochemical detection of Ki67 nuclear antigen.
4 ant acid phosphatase, and proliferating cell nuclear antigen.
5 t also had high levels of proliferative cell nuclear antigen.
6 er than expression of the latency-associated nuclear antigen.
7 companied by production of autoantibodies to nuclear antigens.
11 mologous proteins such as Epstein-Barr virus nuclear antigen 1 (EBNA-1) of the related gamma-herpesvi
13 s, but also efficiently present targeted EBV nuclear antigen 1 (EBNA1) and EBV-latent membrane protei
16 dentical to that found in Epstein-Barr virus nuclear antigen 1 (EBNA1) that interacts with the N-term
18 d nuclear antigen 1 (LANA1) and Epstein-Barr nuclear antigen 1 (EBNA1)] necessary to maintain and rep
19 Nrf2 interacted with KSHV latency-associated nuclear antigen 1 (LANA-1) and the host transcriptional
20 in cells expressing only latency-associated nuclear antigen 1 (LANA-1) protein, and in KSHV latently
21 he expression of the KSHV latency-associated nuclear antigen 1 (LANA-1; ORF73) and LANA-1 nuclear pun
22 express nuclear antigens [latency-associated nuclear antigen 1 (LANA1) and Epstein-Barr nuclear antig
23 ciated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) protein is constitutively expr
25 cargos such as STAT1 and Epstein-Barr Virus Nuclear Antigen 1, as well as the influenza virus polyme
26 -LMPpoly has been generated that encodes EBV nuclear antigen-1 (EBNA1) fused to multiple CD8(+) T-cel
27 V viral capsid antigen positive Epstein-Barr nuclear antigen-1 positive serostatus at transplant (p =
28 ats (GAr) from the EBNA1 (Epstein-Barr virus nuclear antigen-1) protein, can trigger partial degradat
34 hich mimics CD40 signaling), and EBV-encoded nuclear antigen 3A (EBNA3A) and EBNA3C (which inhibit on
40 ence of NKT cells hepatic proliferating cell nuclear antigen and cyclin B1 decreased in mice injected
41 ntly (P < 0.05) inhibited proliferating cell nuclear antigen and cyclin D and caused considerable apo
42 ication factor C-Delta1N, proliferating cell nuclear antigen and DNA polymerase delta was found to re
43 d in the presence of both proliferating cell nuclear antigen and DNA, but the activity was not shut d
44 ation and associated with proliferating cell nuclear antigen and other components of the DNA replicat
45 Whereas association with proliferating cell nuclear antigen and participation in processive genome r
47 nuclear antigen 1 (EBNA1) is the EBV-encoded nuclear antigen and sequence-specific DNA binding protei
51 th the accessory proteins proliferating cell nuclear antigen and the clamp loader replication factor
54 ly, these events promote the accumulation of nuclear antigens and activate innate sensors that drive
55 ays showed 15 IgG autoantibodies (10 against nuclear antigens) and 4 IgM autoantibodies that were dif
56 ylation-resistant form of proliferating cell nuclear antigen, and chromatin loading of FA core comple
57 human systems, MutSalpha, proliferating cell nuclear antigen, and replication factor C activate MutLa
58 for BrdU, the mature neuron marker neuronal nuclear antigen, and the astrocytic marker glial fibrill
59 ASMC proliferation (Ki67, proliferating cell nuclear antigen, and WST1 assays) and resistance to apop
60 Amerindians and tested for HHV-8 anti-latent nuclear antigen (anti-LANA) and antilytic antibodies by
61 onegative recipients was associated with EBV nuclear antigen antibody deficiency, polymorphic disease
63 by an increased number of proliferative cell nuclear antigen assay (PCNA)-positive cells even at days
64 Here, we show that the proliferating cell nuclear antigen-associated factor (Paf) is highly expres
65 l characterization of the proliferating-cell-nuclear-antigen-associated factor p15(PAF), showing that
66 nti-double-stranded DNA and anti-extractable nuclear antigen autoantibodies following treatment with
67 leading strand, and PCNA (proliferating cell nuclear antigen) binds tightly to Pol delta and recruits
68 methyltetrazolium, Ki-67, proliferating cell nuclear antigen, bromodeoxyuridine, and caspase-Glo 3/7
69 eration was assessed with proliferating cell nuclear antigen, CD1, and Ki67 markers and along with as
70 , mature dendritic cells, proliferating cell nuclear antigen+ cells, and monocyte chemoattractant pro
71 narily interacts with the proliferating cell nuclear antigen clamp loader replication factor C, DNA p
73 and protein expression of proliferating cell nuclear antigen, cyclin D1, E-cadherin, beta-catenin, Dv
74 inding protects Set8 from proliferating cell nuclear antigen-dependent degradation during the cell cy
75 hPol delta in supporting proliferating cell nuclear antigen-dependent elongation of DNA chains, whic
76 es and is characterized by the production of nuclear antigen-directed autoantibodies (e.g., anti-dsDN
77 ere IgG seropositivity to Epstein-Barr virus nuclear antigen (EBNA) (random effects odds ratio [OR] 4
79 blastoid Cell Lines (LCLs) requires four EBV nuclear antigen (EBNA) oncoproteins: EBNA2, EBNALP, EBNA
80 ent for expression of the Epstein-Barr Virus nuclear antigen (EBNA), making it particularly beneficia
84 d Cp, resulting in the expression of six EBV nuclear antigens (EBNAs) and the viral Bcl2 homologue BH
85 may ensure against overexpression of the EBV nuclear antigens (EBNAs) prior to the transcriptional re
86 EBV latent membrane proteins (LMPs) and EBV nuclear antigens (EBNAs), as well as nontranslated viral
87 oxyuridine incorporation, proliferating cell nuclear antigen expression, and histone H3 phosphorylati
88 tion-PCR and detection of latency-associated nuclear antigen expression, respectively, in cell lysate
89 sured by doublecortin and proliferating cell nuclear antigen expression, was also suppressed after ne
90 SINTE BRANCHED1/CYCLOIDEA/PROLIFERATING CELL NUCLEAR ANTIGEN FACTOR) family of DNA-binding proteins,
91 to both the EBV viral capsid antigen and EBV nuclear antigen, followed by a more rapid rise in antibo
95 , EBV latent membrane protein-1 and -2A, EBV nuclear antigen, HBV-encoded X antigen, and nonstructura
96 viral genes included the latency-associated nuclear antigen homolog ORF73 but none of the regions kn
99 cyclin D1, E, and A, and proliferating cell nuclear antigen in meningeal cells while significantly r
100 or mono-ubiquitination of proliferating-cell nuclear antigen in response to oxidative DNA damage, whi
101 creased expression of proliferating cellular nuclear antigen in Sertoli cells were observed in Ppard(
102 ignificantly prevented reduction of neuronal nuclear antigen in the infarcted area, although no impro
103 conclusion, lower IgG autoantibodies against nuclear antigens in DLE+SLE+ versus DLE-SLE+ subjects su
104 tibodies, many of which are directed against nuclear antigens, in particular double-stranded (ds) DNA
105 n its recently identified proliferating cell nuclear antigen-interacting motif, which is required for
107 tion that p12 possesses a proliferating cell nuclear antigen-interacting protein-degron (PIP-degron)
108 ic polymerase domain, the proliferating cell nuclear antigen-interacting region, the Rev1-interacting
109 ct regions, including the proliferating-cell-nuclear-antigen-interacting protein motif (PIP-box) and
111 ch compete for binding to proliferating cell nuclear antigen, is critical to prevent genomic instabil
112 rmal thickening, blocked the accumulation of nuclear antigen Ki67(+) cells in the basal and the supra
113 we show that KSHV-encoded latency-associated nuclear antigen (LANA) disrupts the association of CIITA
114 increased numbers of KSHV latency-associated nuclear antigen (LANA) dots, as detected by immunofluore
118 KSHV latency by inducing latency-associated nuclear antigen (LANA) expression during early stages of
119 ls of mRNAs encoding KSHV latency-associated nuclear antigen (LANA) in primary effusion lymphoma (PEL
120 ciated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) is a 1,162-amino-acid protein tha
125 ciated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) is a multifunctional protein with
134 Using immunofluorescence labeling of latent nuclear antigen (LANA) protein, together with fluorescen
135 geted by the KSHV-encoded latency-associated nuclear antigen (LANA) to repress expression of the majo
137 aposi sarcoma herpesvirus latency-associated nuclear antigen (LANA)(1-23), human papillomavirus 8 E2,
138 on of the virally encoded latency-associated nuclear antigen (LANA), a marker of latent KSHV infectio
140 to the host chromosome by latency associated nuclear antigen (LANA), which binds in the terminal repe
147 irus (KSHV) infection and latency-associated nuclear antigen (LANA-1) upregulate the multifunctional
148 ion and the expression of latency-associated nuclear antigen (LANA-1) upregulates the angiogenic mult
149 on of the highly abundant latency-associated nuclear antigen, LANA, on the host genome and its impact
150 BV) are human DNA tumor viruses that express nuclear antigens [latency-associated nuclear antigen 1 (
151 The diversity of the latency protein EBV nuclear antigen leader protein (EBNA-LP) resides predomi
152 replication factor C, and proliferating cell nuclear antigen, long leading strands (>10 kb) are produ
154 ibosomal protein L16; in humans, MYC-induced nuclear antigen (MINA53; also known as MINA) and nucleol
155 ddress the role of MuHV-4 latency-associated nuclear antigen (mLANA) E3 ligase activity in gammaherpe
157 th induced Rad18-mediated proliferating cell nuclear antigen mono-ubiquitination during G(0), G(1) an
158 NA synthesis initiated by proliferating cell nuclear antigen monoubiquitination or less well-characte
159 s of DNA damage, inducing proliferating cell nuclear antigen monoubiquitination, and suppressing muta
160 hrenia and 38 control subjects) for neuronal nuclear antigen (NeuN+) and 65/67 kDa isoform of glutami
161 nt reduction in levels of proliferating cell nuclear antigen, NF-kappabeta/p50, cyclooxygenase-2, and
162 and of the 6 latency-associated EBV-encoded nuclear antigens, only EBNA3B is completely dispensable
163 polymerase sliding clamp, proliferating cell nuclear antigen or PCNA, is a ring-shaped protein comple
164 DNA substrates and either proliferating cell nuclear antigen or the checkpoint sliding clamp 9-1-1.
165 We found that fungal proliferating cell nuclear antigen-partner interaction networks diverged in
167 n, which binds DNA-loaded proliferating cell nuclear antigen (PCNA(DNA)) and recruits CRL4(Cdt2).
168 During DNA replication, proliferating cell nuclear antigen (PCNA) adopts a ring-shaped structure to
170 expression of cyclins and proliferating cell nuclear antigen (PCNA) and evidence for DNA replication
171 sed platinum drug-induced proliferating cell nuclear antigen (PCNA) and FANCD2 monoubiquitinations (s
172 53 increased the level of proliferating cell nuclear antigen (PCNA) and minichromosome maintenance 4
173 red box protein 7 (Pax7), proliferating cell nuclear antigen (PCNA) and nicotinamide phosphoribosyltr
174 on factories by retaining proliferating cell nuclear antigen (PCNA) and other replisome proteins on t
175 tone substrates including proliferating cell nuclear antigen (PCNA) and promotes carcinogenesis by de
176 ctions with two proteins, Proliferating Cell Nuclear Antigen (PCNA) and Replication Protein A (RPA),
177 ocessivity clamps such as proliferating cell nuclear antigen (PCNA) and the checkpoint sliding clamp
178 ication accessory protein proliferating cell nuclear antigen (PCNA) and the scaffold protein Rev1.
179 nary complexes containing proliferating cell nuclear antigen (PCNA) and two non-classical DNA polymer
180 study, we identified the proliferating cell nuclear antigen (PCNA) as a nIGF-1R-binding partner.
181 hat the sliding DNA clamp proliferating cell nuclear antigen (PCNA) associates with the C-terminal do
182 Here, we investigated proliferating cell nuclear antigen (PCNA) binding and opening by the Saccha
183 F-1 p150 was deficient in proliferating cell nuclear antigen (PCNA) binding, reinforcing the existenc
184 and polyubiquitination of proliferating cell nuclear antigen (PCNA) by regulating the recruitment of
185 tethering of Polkappa to proliferating cell nuclear antigen (PCNA) circumvents the need for its ubiq
186 t events in the reaction: proliferating cell nuclear antigen (PCNA) clamp binding/opening/closure/rel
187 C) complex loads circular proliferating cell nuclear antigen (PCNA) clamps onto DNA where they serve
188 ubunit complex that loads proliferating cell nuclear antigen (PCNA) clamps onto primer-template DNA (
189 Saccharomyces cerevisiae proliferating cell nuclear antigen (PCNA) clamps using single-molecule appr
190 cle actin (alpha-SMA) and proliferating cell nuclear antigen (PCNA) compared with 2- and 3-copy mice.
191 yuridine (BrdU) labeling, proliferating cell nuclear antigen (PCNA) expression and mitotic index incr
192 bp1), a key in regulating proliferating cell nuclear antigen (PCNA) expression and ribosomal RNA (rRN
197 eling as well as Ki67 and proliferating cell nuclear antigen (PCNA) immunofluorescence, we determined
198 Saccharomyces cerevisiae proliferating cell nuclear antigen (PCNA) in replication factor C (RFC)-cat
199 the sliding clamp protein proliferating cell nuclear antigen (PCNA) in response to DNA damage, exhibi
200 h consists of a canonical proliferating cell nuclear antigen (PCNA) interaction motif (PIP box) and a
209 The sliding clamp protein proliferating cell nuclear antigen (PCNA) is situated at the core of the eu
212 erturbation that supports proliferating cell nuclear antigen (PCNA) loading by replication factor C,
213 se and during DNA repair, proliferating cell nuclear antigen (PCNA) loading onto DNA (PCNA(DNA)) trig
214 omotrimeric sliding clamp proliferating cell nuclear antigen (PCNA) mediates Okazaki fragment maturat
215 se RAD18 is necessary for proliferating cell nuclear antigen (PCNA) monoubiquitination and TLS polyme
216 7 promoted the UV-induced proliferating cell nuclear antigen (PCNA) monoubiquitination in Poleta-prof
218 ependent kinase (CDK) and proliferating cell nuclear antigen (PCNA) onto chromatin, as well as initia
221 wn that monoubiquitinated proliferating cell nuclear antigen (PCNA) plays an important role in recrui
222 raction between RECQ5 and proliferating cell nuclear antigen (PCNA) promotes RAD18-dependent PCNA ubi
223 P-box sequence peptide to proliferating cell nuclear antigen (PCNA) protein by competing for the same
224 mplate and anchors to the proliferating cell nuclear antigen (PCNA) sliding clamp to form a holoenzym
225 synthesizing DNA with the proliferating cell nuclear antigen (PCNA) sliding clamp; however, it has re
226 evels of doublecortin and Proliferating Cell Nuclear Antigen (PCNA) suggested increased neurogenesis.
229 titutively interacts with proliferating cell nuclear antigen (PCNA) via a highly conserved PIP box mo
230 brain mantle and express proliferating cell nuclear antigen (PCNA), a cell cycling marker, indicate
231 RV2) and the host-encoded proliferating cell nuclear antigen (PCNA), a key DNA replication protein in
232 ow that monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA), a marker of stalled replication
233 cently described that the proliferating cell nuclear antigen (PCNA), a nuclear factor involved in DNA
235 acidophilum interact with proliferating cell nuclear antigen (PCNA), an essential co-factor for DNA p
236 the recruitment of Cdc45, proliferating cell nuclear antigen (PCNA), and polymerase delta, but not OR
238 Msh2-Msh6 (or Msh2-Msh3), proliferating cell nuclear antigen (PCNA), and replication factor C (RFC) a
240 complex monoubiquitinates proliferating cell nuclear antigen (PCNA), but the basis for recruitment of
242 n A, pRb (Ser249/Thr252), proliferative cell nuclear antigen (PCNA), cyclin D1 with elevated levels o
243 age and monoubiquitinates proliferating cell nuclear antigen (PCNA), facilitating engagement of Polet
244 nding capability of human proliferating cell nuclear antigen (PCNA), identified the lysine residue in
245 ability to interact with proliferating cell nuclear antigen (PCNA), it enhances its interaction with
247 Increased expression of proliferating cell nuclear antigen (PCNA), TGF-beta, and p-AKT and decrease
249 1 inhibits recruitment of proliferating cell nuclear antigen (PCNA), the platform for assembly of the
251 mbly might be governed by proliferating cell nuclear antigen (PCNA), the processivity factor of repli
252 eplicative sliding clamp, proliferating cell nuclear antigen (PCNA), the UBZ domain facilitates recru
253 its are also required for proliferating cell nuclear antigen (PCNA)-dependent TLS by Pol zeta as Pol
254 Lack of SIM, but not proliferating cell nuclear antigen (PCNA)-interacting motif (PIM), leads to
269 ll molecule inhibitors of proliferating cell nuclear antigen (PCNA)/PCNA interacting protein box (PIP
270 ocessivity clamps such as proliferating cell nuclear antigen (PCNA); however, the exact mechanism of
271 e heterotrimeric PCNA123 [proliferating cell nuclear antigen (PCNA)] clamp onto DNA that includes a r
272 tivity (analyses of Ki67, proliferating cell nuclear antigen, phosphorylated histone 3, mitosis, and
273 e-positive cells and more proliferating cell nuclear antigen-positive cells in all treatment groups r
275 (P < 0.05) the number of proliferating cell nuclear antigen-positive tubular epithelial cells at 24
276 raction between XEco2 and proliferating cell nuclear antigen prevents cohesion establishment while ha
277 IgG:IgM ratios of autoantibodies against nuclear antigens progressively rose from healthy to DLE-
278 report an ancient family of GCNA (germ cell nuclear antigen) proteins that arose in the earliest euk
279 on polyubiquitylation of proliferating cell nuclear antigen provides a backup mechanism for accurate
280 tional inner mitochondrial enzymes, and four nuclear antigens remain immunologically intact with resp
281 tive DNA polymerase delta/proliferating cell nuclear antigen/replication factor C complex on telomeri
282 ell cycle (e.g. P. patens proliferating cell nuclear antigen, ribonucleotide reductase, and minichrom
283 lation of chromatin-bound proliferating cell nuclear antigen, slowed cell division, and increased gen
286 replication factor C and proliferating cell nuclear antigen to perform efficient DNA synthesis in vi
287 stimation; apoptosis with proliferating cell nuclear antigen, TUNEL, and caspase assays; and gene exp
288 tions and perform IHC for proliferating cell nuclear antigen, upstream binding factor, RNA polymerase
289 n by ubiquitinating PCNA (proliferating cell nuclear antigen) using the RAD6-RAD18 and UBC13-MMS2-RAD
290 estasis, but unexpectedly proliferating cell nuclear antigen was down-regulated at 12 days after chol
291 LR assessed by Ki-67 and proliferating cell nuclear antigen was markedly decreased in Itpr2(-/-) mic
292 ce, whereas cyclin D1 and proliferating cell nuclear antigen were decreased to reduce cell proliferat
293 ant acid phosphatase, and proliferating cell nuclear antigen were evaluated by histochemical and immu
294 of hepatic cyclin B1 and proliferating cell nuclear antigen were evaluated by Western Blot and liver
296 cated by co-staining with proliferating cell nuclear antigen, whereas Notch3 was expressed throughout
297 NANCE 2-7 gene family and PROLIFERATING CELL NUCLEAR ANTIGEN, which encode essential DNA replication
299 the proliferation marker proliferating cell nuclear antigen while also displaying a reduction in epi
300 ractions of S. cerevisiae Proliferating Cell Nuclear Antigen (yPCNA) with modified DNA sequences and
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。